Upadacitinib

ATC L04AF03 · 8 markets · 23 records

Upadacitinib 8 markets · 23 records Forms

US 4 records · 4 strengths

GB 3 records · 3 strengths

CA 3 records · 3 strengths

AU 3 records · 3 strengths

ES 3 records · 3 strengths

HK 3 records · 1 strengths

    Records without a stated strength · 1 RINVOQ PROLONGED-RELEASE TABLETS 15MG

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 Rinvoq

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.